Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

November 2016 - FRMC

Department
Biologic Utilization Varies Widely for RA Treatment
11/22/2016
Recent research presented at AMCP Nexus 2016 found that biologic utilization prevalence for the treatment of rheumatoid arthritis (RA) varied widely between Humira (adalimumab; Janssen), Cimzia (certolizumab; UCB Inc), Enbrel (etanercept;...
Recent research presented at AMCP Nexus 2016 found that biologic utilization prevalence for the treatment of rheumatoid arthritis (RA) varied widely between Humira (adalimumab; Janssen), Cimzia (certolizumab; UCB Inc), Enbrel (etanercept;...
Recent research presented at...
11/22/2016
First Report Managed Care
Department
Pain Guardian Program Reduces Opioid Use
11/22/2016
Analysis of the effectiveness of Pain Guardian, a clinical program aimed at curbing opioid abuse and waste, showed that the program significantly decreased opioid utilization, according to a poster presented at AMCP Nexus 2016. 
Analysis of the effectiveness of Pain Guardian, a clinical program aimed at curbing opioid abuse and waste, showed that the program significantly decreased opioid utilization, according to a poster presented at AMCP Nexus 2016. 
Analysis of the effectiveness of...
11/22/2016
First Report Managed Care
Department
Cardiovascular Disease Mortality Associated With Increased Costs Among Patients With Diabetes
11/22/2016
Patients with type 2 diabetes who suffer fatal cardiovascular disease (CVD) events have significantly increased health care costs during the last year of treatment, according to recent research presented at AMCP Nexus 2016.
Patients with type 2 diabetes who suffer fatal cardiovascular disease (CVD) events have significantly increased health care costs during the last year of treatment, according to recent research presented at AMCP Nexus 2016.
Patients with type 2 diabetes...
11/22/2016
First Report Managed Care
Department
Estimation Methods May Not Be Reliable for Projecting Type 2 Diabetes Treatment Costs
11/22/2016
An examination of two different cost estimation methods revealed that health care costs associated with type 2 diabetes varied widely depending on which system was used, suggesting that these tools are unreliable for payers, according to a...
An examination of two different cost estimation methods revealed that health care costs associated with type 2 diabetes varied widely depending on which system was used, suggesting that these tools are unreliable for payers, according to a...
An examination of two different...
11/22/2016
First Report Managed Care
Department
Zepatier Less Costly, More Effective Than Harvoni, Epclusa for Hepatitis C
11/22/2016
According to recent research presented at AMCP Nexus 2016, hepatitis C genotype 1 treatment with Zepatier (elbasvir/grazoprevir; Merck) was more effective and less expensive when compared to Harvoni (ledipasvir/sofosbuvir; Gilead) and...
According to recent research presented at AMCP Nexus 2016, hepatitis C genotype 1 treatment with Zepatier (elbasvir/grazoprevir; Merck) was more effective and less expensive when compared to Harvoni (ledipasvir/sofosbuvir; Gilead) and...
According to recent research...
11/22/2016
First Report Managed Care
Department
RA Drug Coverage Inconsistent Among Largest Private Payers
11/22/2016
According to a poster presentation at AMCP Nexus 2016, the country’s largest private health care payers cover rheumatoid arthritis (RA) drugs inconsistently and use different evidence to support their coverage policy decisions. 
According to a poster presentation at AMCP Nexus 2016, the country’s largest private health care payers cover rheumatoid arthritis (RA) drugs inconsistently and use different evidence to support their coverage policy decisions. 
According to a poster...
11/22/2016
First Report Managed Care
Department
Breakthrough RA, MS Treatments Among Anticipated Drugs in Specialty Pipeline
11/22/2016
During the AMCP Nexus 2016 meeting, Aimee Tharaldson outlined the specialty treatments likely to receive FDA approval in the coming months.
During the AMCP Nexus 2016 meeting, Aimee Tharaldson outlined the specialty treatments likely to receive FDA approval in the coming months.
During the AMCP Nexus 2016...
11/22/2016
First Report Managed Care
Department
Is NASH the Next Hep C? Bracing for a Massive Impact On Spending
11/22/2016
During an educational session at AMCP Nexus 2016, Sara C Erickson, PharmD, health outcomes researcher at MedImpact Healthcare Systems, and Susan Trieu, PharmD, drug information pharmacist at MedImpact Healthcare Systems, presented data...
During an educational session at AMCP Nexus 2016, Sara C Erickson, PharmD, health outcomes researcher at MedImpact Healthcare Systems, and Susan Trieu, PharmD, drug information pharmacist at MedImpact Healthcare Systems, presented data...
During an educational session at...
11/22/2016
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Cigna Reports Cost Savings Associated With Fusing Medical, Drug, and Behavioral Benefits
01/07/2020
"Our integrated approach maximizes every opportunity to deliver a health care experience that is affordable, predictable and simple," said Matt Totterdale, senior vice president, Cigna Pharmacy.
"Our integrated approach maximizes every opportunity to deliver a health care experience that is affordable, predictable and simple," said Matt Totterdale, senior vice president, Cigna Pharmacy.
"Our integrated approach...
01/07/2020
First Report Managed Care
News
Foes of new health system more likely to vote Nov. 2
09/27/2010
09/27/2010
First Report Managed Care
Conference Insider
New Shingles Vaccine Cost-Effective, Cost-Saving Compared With Zostavax
05/31/2018
Research presented at the AMCP 2018 Annual Meeting found that Shingrix (non-live adjuvanted subunit vaccine; GlaxosmithKline) is cost-effective when compared with no vaccination and cost-saving compared with an older shingles vaccine.
Research presented at the AMCP 2018 Annual Meeting found that Shingrix (non-live adjuvanted subunit vaccine; GlaxosmithKline) is cost-effective when compared with no vaccination and cost-saving compared with an older shingles vaccine.
Research presented at the AMCP...
05/31/2018
First Report Managed Care
News
Jentadueto Approved for Type 2 Diabetes
01/31/2012
The US Food and Drug Administration (FDA) announced on Monday that it had approved Jentadueto (linagliptin/metformin hydrochloride), an oral combination therapy to treat patients with type 2 diabetes. The drug is co-marketed by Boehringer...
The US Food and Drug Administration (FDA) announced on Monday that it had approved Jentadueto (linagliptin/metformin hydrochloride), an oral combination therapy to treat patients with type 2 diabetes. The drug is co-marketed by Boehringer...
The US Food and Drug...
01/31/2012
First Report Managed Care
News
Value-Based Contracting Showing Greater Value for Care Provided, Innovative Opportunities
07/13/2015
San Diego—Value-based contracting is demonstrating greater value for care provided, while innovative contracting opportunities are expected to increase in the future, according to a session at the AMCP meeting that included both payer and...
San Diego—Value-based contracting is demonstrating greater value for care provided, while innovative contracting opportunities are expected to increase in the future, according to a session at the AMCP meeting that included both payer and...
San Diego—Value-based...
07/13/2015
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

November 2016 Volume 13 Issue 11

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement